Deerfield Management

Portfolio Co Investors 2026 for Deerfield Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Deerfield Management accounts for 53 tracked companies with verified cap-table data, 53 of which disclose round sizes totalling $8.3B. The median disclosed raise is $110M, and the largest is Credibly at $1B, ahead of Edgewise Therapeutics ($495M) and Homology Medicines ($456M).

The names that recur most often on these co-invested cap tables are Deerfield Management (53 companies), ARCH Venture Partners (5 companies), OrbiMed (4 companies), RA Capital Management (4 companies), Venrock (3 companies), Foresite Capital (3 companies). By latest disclosed round, the market skews Series B (16), Series A (13), Series C (8), Growth (4).

Best funded Deerfield Management companies

  1. Credibly — $1B
  2. Edgewise Therapeutics — $495M (latest: Growth)
  3. Homology Medicines — $456M (latest: Growth)
  4. Lumeris — $406M (latest: Growth)
  5. Singular Genomics — $384M (latest: IPO)
  6. Nuvalent — $336M (latest: IPO)
  7. Crossover Health — $292M (latest: Series D)
  8. Ray Therapeutics — $230M (latest: Series B)
  9. BridgeBio Oncology Therapeutics — $200M (latest: Growth)
  10. Black Diamond Therapeutics — $194M (latest: Series C)
  11. Lark — $185M
  12. Proteon Therapeutics — $185M (latest: Series A)
  13. Pairwise Plants — $180M (latest: Series C)
  14. Pairwise Plants LLC — $180M (latest: Series C)
  15. ConcertoCare — $170M (latest: Series B)

Deerfield Management — related firms and companies (56)

Deerfield Management alternatives · All research reports